GRN

STAINING OVERVIEW

? »

Overall cancer tissue 
staining statistics


0%
25%
50%
75%
100%

Tissue presentation order

Histological

Alphabetical

 

Antibody HPA008763

Antibody HPA028747

Antibody CAB019394

Tissue

Antibody staining

Antibody staining

Antibody staining

Colorectal cancer
Breast cancer
Prostate cancer
Ovarian cancer
Cervical cancer
Endometrial cancer
Carcinoid
Head and neck cancer
Thyroid cancer
Glioma
Lymphoma
Lung cancer
Melanoma
Skin cancer
Testis cancer
Urothelial cancer
Renal cancer
Stomach cancer
Pancreatic cancer
Liver cancer

Summary

Most malignant cells were weakly stained or negative. A majority of malignant melanomas and several cases of malignant gliomas showed moderate cytoplasmic positivity. Moderate to strong cytoplasmic, often granular, immunoreactivity was observed in most malignant cells. Prostate cancers and some malignant melanomas, colorectal, endometrial and liver cancer showed strong positivity. Cases of malignant gliomas and lymphomas were negative.Prostate cancers as well as several cases of malignant melanomas, urothelial cancers and hepatocellular carcinomas were moderate to strongly stained. Remaining malignancies were generally negative.

Validation

Uncertain: Two (or more) antibodies yielding partly similar staining patterns which are partly consistent with gene/protein characterization data or consistent with limited gene/protein characterization data
Uncertain: Two (or more) antibodies yielding partly similar staining patterns which are partly consistent with gene/protein characterization data or consistent with limited gene/protein characterization data
Uncertain: Two (or more) antibodies yielding partly similar staining patterns which are partly consistent with gene/protein characterization data or consistent with limited gene/protein characterization data

Level of antibody staining/expression





High
Medium
Low
Not detected